QUESTCOR PHARMACEUTICALS INC Net Change in Cash
QUESTCOR PHARMACEUTICALS INC reported Net Change in Cash of $155.84 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-07-25.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2014-07-25
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2014-06-30 was $70.58M, a 1009.53% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2014-03-31 was $85.26M.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2013-12-31 was -$15.01M, a 133.69% decline year-over-year.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for the quarter ending 2013-09-30 was $109.08M.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for fiscal 2013 was $95.23M.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for fiscal 2012 was -$7.86M, a 116.74% decline from fiscal 2011.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for fiscal 2011 was $46.96M.
- QUESTCOR PHARMACEUTICALS INC cash and cash equivalents, period increase (decrease) for fiscal 2010 was -$4.32M, a 113.28% decline from fiscal 2009.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2014-06-30 | $70.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $155.84M 10-Q · filed 2014-07-25 | $140.83M derived: sum of 3 quarters · filed 2014-07-25 | $249.91M derived: sum of 4 quarters · filed 2014-07-25 |
| 2014-03-31 | $85.26M 10-Q · filed 2014-04-29 | $70.26M derived: sum of 2 quarters · filed 2014-04-29 | $179.34M derived: sum of 3 quarters · filed 2014-04-29 | $185.70M derived: sum of 4 quarters · filed 2014-07-25 |
| 2013-12-31 | -$15.01M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $94.08M derived: sum of 2 quarters · filed 2014-02-26 | $100.44M derived: sum of 3 quarters · filed 2014-07-25 | $95.23M 10-K · filed 2014-02-26 |
| 2013-09-30 | $109.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $115.44M derived: sum of 2 quarters · filed 2014-07-25 | $110.24M 10-Q · filed 2013-10-30 | $154.77M derived: sum of 4 quarters · filed 2014-07-25 |
| 2013-06-30 | $6.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-25 | $1.16M 10-Q · filed 2014-07-25 | $45.69M derived: sum of 3 quarters · filed 2014-07-25 | $45.10M derived: sum of 4 quarters · filed 2014-07-25 |
| 2013-03-31 | -$5.20M 10-Q · filed 2014-04-29 | $39.33M derived: sum of 2 quarters · filed 2014-04-29 | $38.74M derived: sum of 3 quarters · filed 2014-04-29 | $11.81M derived: sum of 4 quarters · filed 2014-04-29 |
| 2012-12-31 | $44.53M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $43.95M derived: sum of 2 quarters · filed 2014-02-26 | $17.02M derived: sum of 3 quarters · filed 2014-02-26 | -$7.86M 10-K · filed 2014-02-26 |
| 2012-09-30 | -$586.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$27.52M derived: sum of 2 quarters · filed 2013-10-30 | -$52.39M 10-Q · filed 2013-10-30 | -$61.03M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | -$26.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | -$51.81M 10-Q · filed 2013-07-31 | -$60.44M derived: sum of 3 quarters · filed 2014-02-26 | -$28.61M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | -$24.88M 10-Q · filed 2013-05-02 | -$33.51M derived: sum of 2 quarters · filed 2014-02-26 | -$1.69M derived: sum of 3 quarters · filed 2014-02-26 | -$2.50M derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | -$8.63M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-02-26 | $23.19M derived: sum of 2 quarters · filed 2014-02-26 | $22.38M derived: sum of 3 quarters · filed 2014-02-26 | $46.96M 10-K · filed 2014-02-26 |
| 2011-09-30 | $31.82M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2012-10-25 | $31.01M derived: sum of 2 quarters · filed 2012-10-25 | $55.59M 10-Q/A · filed 2012-10-25 | $51.48M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | -$812.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-25 | $23.77M 10-Q · filed 2012-07-25 | $19.66M derived: sum of 3 quarters · filed 2013-02-27 | $41.45M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $24.58M 10-Q · filed 2012-04-26 | $20.47M derived: sum of 2 quarters · filed 2013-02-27 | $42.27M derived: sum of 3 quarters · filed 2013-02-27 | |
| 2010-12-31 | -$4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $17.68M derived: sum of 2 quarters · filed 2013-02-27 | -$4.32M 10-K · filed 2013-02-27 | |
| 2010-09-30 | $21.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$207.00K 10-Q · filed 2011-10-27 | ||
| 2010-06-30 | -$22.00M 10-Q · filed 2011-07-29 | |||
| 2009-12-31 | $32.55M 10-K/A · filed 2012-03-19 |